What the published trials show

Weight loss

In the main trials, people lost roughly 15 percent of their body weight over about 16 months on the first medication, and up to 20 percent over about 17 months on the dual-action one, alongside basic diet and activity guidance. For a 220-pound person that is 33 to 44 pounds. Those are averages. Some lost more, some less, and a small share did not respond.

Beyond the scale

A large outcomes trial published in 2023, in people with heart disease and excess weight, found a roughly 20 percent reduction in major cardiovascular events over about three years. Blood pressure, blood sugar, and markers of inflammation improved across the trials. This is where longevity earns its place in the name of this site. The medication is one lever, but the weight it helps remove is the weight your heart and joints have been carrying.

What happens when you stop

In a published follow-up, people who stopped the medication regained about two-thirds of the weight they had lost within a year, and most of the improvements in blood pressure and blood sugar went with it. Read that again. It means two things. This is a long-term tool, not a twelve-week run. And the other four levers are what you'll be standing on when the support tapers. Anyone who sells it to you as a short program is selling you the regain.

Muscle

In one sub-study, a sizable share of the weight lost was lean mass rather than fat, close to 40 percent. That is not unique to the medication. It happens with any fast weight loss. It is why protein and strength training are not optional on this path, and why the scale alone is the wrong measure.

Side effects

The common ones are digestive: nausea, constipation, diarrhea, and vomiting, most often during the first weeks and when the amount is increased. They are the reason the amount is raised slowly. Less common and more serious: inflammation of the pancreas, gallbladder problems, and low blood sugar when combined with certain diabetes medications. The medications carry a warning about thyroid tumors seen in rodent studies, which is why anyone with a personal or family history of certain thyroid cancers is ruled out. A prescriber who doesn't ask about this is a red flag.

The other four levers

Muscle mass and strength predict how long and how well people live; grip strength alone is one of the stronger predictors in large population studies. Short sleep raises hunger hormones and food intake within days in controlled studies. Chronic stress is linked to abdominal fat and to the cravings that break plans. And the behavior-change research is consistent: people keep the habits that match their sense of who they are. None of this is new. It is just rarely done.

Sources to read

• The FDA prescribing information for the approved medications in this class
• The National Institute of Diabetes and Digestive and Kidney Diseases page on prescription medications for weight management
• The Mayo Clinic patient pages on this class of medication
• The trial publications in The New England Journal of Medicine and JAMA, including the follow-up on stopping